Chronic myeloid leukemia (CML) accounts for 2‐3% of leukemias in children under 15 and
9% in adolescents aged 15‐19. The diagnosis and management of CML in children …

There are few data showing biological differences between adult and pediatric chronic
myelogenous leukemia (CML), but the clinical presentations are distinct and the host factors …

Chronic myeloid leukaemia in children and young people is a relatively rare form of
leukaemia that shows increased incidence with age and some evidence suggests that the …

Chronic myelogenous leukemia (CML) in children is relatively rare. Because of a lack of
robust clinical study evidence, management of CML in children is not standardized and often …

Abstract 3741 Background: CML is a very rare disease in children and adolescents
accounting for less than 5% of all CML cases. Only scant data is available regarding …

The incidence of chronic myeloid leukaemia (CML) ranges between 10 and 15
cases/106/year without any major geographic or ethnic differences [1]. The median age at …

Evidence-based recommendations have been established for treatment of chronic myeloid
leukemia (CML) in adults treated with tyrosine kinase inhibitors (TKIs), but the rarity of this …

Juvenile chronic myelogenous leukemia (JCML) is a malignant hematopoietic disorder of
monocyte—histiocyte lineage that affects children less than 4 years of age. Since the …

Abstract Purpose of Review Due to lack of pediatric-specific data, the management of
chronic myeloid leukemia (CML) in pediatric, adolescents, and young adults is guided by …

Background Chronic myeloid leukaemia (CML) is very rare in children. The aim of the study
is to report the experience within the I-CML-Ped study in children and adolescents …